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Background: Current guidelines recommend the use of clinical decision rules, such as Wells score, in 
combination with D-dimer to assess the need for objective imaging to rule out deep vein thrombosis 
(DVT). However, the clinical decision rule has limitations, and use of D-dimer as a stand-alone test has 
been suggested.   
Objective: We aimed to assess the safety and efficiency of D-dimer as a stand-alone test to rule out DVT 
in outpatients referred with suspected DVT.  
Methods: We collected data from consecutive outpatients referred to our hospital with suspected DVT 
in 2008-2018. D-dimer levels were analyzed using STA® Liatest® D-Di assay. D-dimer as a stand-alone test 
was theoretically applied in retrospect, and the number of misdiagnosed events were estimated as if 
such an approach had been initially used. All patients were followed for three months. 
Results: Of 1765 included patients, 293 (16.6%) were diagnosed with DVT. A total of 491 patients (27.8%) 
had a negative D-dimer (<500 ng/mL). Of these, nine were diagnosed with DVT, yielding a failure rate for 
D-dimer as a stand-alone test of 1.8% (95% CI 0.8%-3.5%). The majority of the misdiagnosed patients had  
distal DVT. In analyses restricted to proximal DVTs, the failure rate was 0.6% (95% CI 0.1%-1.8%). D-
dimer as a stand-alone approach reduced the proportion of required ultrasounds from 81.8% to 72.2%.  
Conclusion: D-dimer as a stand-alone test may be safe for excluding proximal DVT and reduce the 







• D-dimer is proposed as a stand-alone test to rule out deep vein thrombosis (DVT). 
 
• We retrospectively explored the safety and efficiency of such a strategy in a large cohort. 
 
• Our findings suggest that D-dimer as a stand-alone test may be safe for excluding proximal DVT. 
 




Introduction   
D-dimer is a commonly used biomarker for coagulation activation and fibrinolysis. For patients with a 
suspected deep vein thrombosis (DVT), current guidelines recommend the use of pretest probability 
assessment and D-dimer test to evaluate whether DVT can be safely ruled out, or whether the patient 
should be referred to further diagnostic work-up with imaging techniques [1-3]. The pretest probability 
assessment is usually performed using Wells score [4], which is a well studied clinical prediction rule for 
DVT [5]. The original score was based on signs, symptoms and risk factors for DVT, and classified patients 
into three risk categories (low, moderate or high probability). A later modification of the Wells score 
additionally incorporated previous DVT as an item and classifies patients into two categories (unlikely or 
likely) based on the total score (<2 or ≥2 points) [6]. If the modified Wells score is <2 points, D-dimer 
should be measured, and DVT can be ruled out with a negative predictive value of 98-99% if the D-dimer 
level is <500 ng/mL [7]. 
Despite the central role of Wells score in the diagnostic work-up of suspected DVT, the clinical 
prediction rule has several limitations. The subjective assessment of some of the score items may 
introduce misclassification [8] and several studies have shown a poor adherence and lack of correct 
implementation of the score in daily clinical practice [9-12]. As many of today’s clinics are organized to 
be as efficient as possible, standard blood samples including D-dimer are often obtained before clinical 
evaluation. Consequently, D-dimer is potentially interpreted before calculating the Wells score, contrary 
to the intention behind the clinical decision rule [13-15]. 
Although D-dimer is typically increased in patients with acute venous thromboembolism (VTE), 
D-dimer levels may also be elevated in several other conditions, such as malignancy, infections, and 
pregnancy, thus decreasing its specificity [16]. Moreover, D-dimer increases with age [17]. Due to a 
decreased specificity among elderly patients with the fixed cut-off value (500 ng/mL), age-adjusted cut-
off values for D-dimer testing has been suggested [17-20]. 
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The use of D-dimer as a stand-alone test to rule out VTE has been proposed, mainly in PE 
patients [21-23]. A strategy that relies entirely on D-dimer to determine the need for objective imaging 
may simplify and optimize the efficiency of the diagnostic work-up and reduce the number of imaging 
tests. In a recent study, Frønæs et al. investigated the safety of D-dimer as a stand-alone test to rule out 
DVT in 913 outpatients referred with suspected DVT. Of 298 (33%) patients with a negative D-dimer, only 
one patient was diagnosed with DVT, yielding a failure rate of 0.3%. These findings indicated that fixed D-
dimer as a stand-alone test could safely exclude DVT while requiring fewer compression ultrasounds 
(CUS) than the combined approach of D-Dimer and Wells score. In the present study, we aimed to 
validate the findings presented by Frønæs et al. in a larger population of unselected VTE patients. We, 
therefore, assessed the safety and efficiency of applying D-dimer as a stand-alone test in outpatients 
consecutively referred to our hospital with suspected DVT. Four diagnostic strategies for excluding DVT 
were investigated and compared: (i) fixed D-dimer as a stand-alone test, (ii) fixed D-dimer combined with 
modified Wells score, (iii) age-adjusted D-dimer as a stand-alone test, and (iv) age-adjusted D-dimer 






Study population  
We collected data from consecutive outpatients referred with a suspected DVT to the Emergency 
Department of the University Hospital of North Norway (UNN), in Tromsø, Norway, between 2008 and 
2018. The UNN is the sole provider of all VTE diagnostic procedures and VTE-related healthcare in the 
Tromsø region, serving a local population of 127 000 inhabitants. A total of 2003 patients was referred 
with a suspected DVT during the 10-year period. Patients with a permanent address outside the 
catchment area of the hospital (n=23), who could not be followed for three months, were excluded. All 
included patients were followed for three months after their visit to the Emergency Department by close 
review of their medical records. Our hospital is the only hospital providing diagnostic and therapeutic 
management of VTE within a radius of 250 km. Thus, the likelihood of a complete follow-up of patients 
living in this catchment area is high. Patients in whom the diagnostic work-up was incomplete, i.e. no D-
dimer measurement (n=18), no assessment of Wells score (n=35), and patients with an insufficient 
imaging test (n=2), were excluded. In addition, patients with ongoing anticoagulation treatment were 
excluded (n=160) (Fig. 1). Consequently, 1765 patients were included in the analyses. The study was 
approved by the regional committee for health and research ethics. 
 
Diagnostic procedure  
All outpatients referred to the Emergency Department with a suspected DVT underwent evaluation by a 
physician using a modified, two-level Wells score and D-dimer test to guide the decision on further 
diagnostic testing. The Wells score was assessed in the Emergency Department using a standardized 
form. D-dimer levels were assayed with the STA®-Liatest D-Di from Stago (Diagnostica Stago, Asnieères, 
France). All blood samples were analyzed at the Department of Clinical Chemistry at the UNN.  
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According to existing clinical practice during the data collection period, all patients with either a 
Wells score ≥2 and/or a positive D-dimer (i.e., ≥500 ng/mL) at baseline, would be referred for further 
CUS. However, the physician’s clinical judgment could also impact the decision, and some of the patients 
with negative fixed D-dimer and low clinical probability underwent objective testing, although this was 
not coherent with the guidelines.  
 Patients referred for further diagnostic testing underwent a whole-leg CUS, assessing all veins of 
the affected extremity for compressibility. Non-compressibility was the main criterion for DVT, but a 
confident gray-scale visualization of the thrombus was also considered diagnostic. In patients where a 
CUS was impractical (e.g., if leg casting or excessive subcutaneous tissue or fluid prevented adequate 
assessment of compressibility) or the result of the CUS was uncertain, venography was performed 
instead or as an additional test.   
All patients were followed for three months. In patients where DVT was ruled out at baseline, a 
diagnosis of DVT occurring in the following three months was considered as an undetected and 
misclassified event from their first visit. Information on DVT during follow-up was obtained by thorough 
review of medical records, using the same criteria for objective verification as described above. DVT 
occurring after the initial three months follow-up period was considered as a new event (i.e., incident or 
recurrent DVT).  
 
Definition of diagnostic strategies 
Four diagnostic strategies for excluding DVT were investigated (Fig. S1). These included (i) fixed D-dimer 
as a stand-alone test; (ii) fixed D-dimer combined with modified Wells score; (iii) age-adjusted D-dimer as 
a stand-alone test; and (iv) age-adjusted D-dimer combined with modified Wells score. In the approaches 
combining a D-dimer with a modified Wells score, all patients with either a positive D-dimer or a Wells 
score ≥2 points (i.e., ‘DVT likely’), were considered as referred for CUS. When using D-dimer as a stand-
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alone test, patients with a D-dimer below the chosen threshold were considered discharged without 
further testing. The fixed D-dimer cut-off was defined as positive when the D-dimer value was ≥500 
ng/mL. For the two strategies that included age-adjusted D-dimer, a positive threshold was defined as ≥ 
age x 10 ng/mL for patients ≥50 years of age (i.e., the cut-off level for a 70-year-old would be ≥700 
ng/mL). For patients <50 years of age, a fixed threshold of ≥500 ng/mL was used. 
In our analyses, which were a post hoc estimation of the diagnostic performance of these four 
different strategies, we theoretically applied the different approaches and used the criteria that would 
have led to a referral for CUS in each diagnostic strategy. However, the estimations were based on the 
assumption that the chosen diagnostic criteria would be followed without exception. For instance, while 
estimating the performance of D-dimer as a stand-alone test, we assumed that all patients with a D-




The failure rate expressed the safety of the strategy and was defined as the proportion of patients who 
did not meet the criteria for undergoing CUS defined by the chosen strategy (i.e., negative tests), but still 
was diagnosed with DVT. The amount of required CUS indirectly expressed the efficiency of the approach 
and was defined as the proportion of patients who met the criteria for undergoing CUS for the chosen 
strategy (i.e. positive tests).  
Since there is an ongoing discussion about the clinical significance of distal DVT with regards to 
further evaluation and treatment [24, 25], we performed a sub-analysis restricted to proximal DVTs. 
Previous studies have shown that ongoing anticoagulant treatment may influence D-dimer levels and 
thereby decrease the sensitivity of the test [26, 27]. In our analyses, patients with ongoing anticoagulant 
treatment were excluded. The current strategies are based on the rationale that the post-test prevalence 
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of DVT might be too high to safely rule out the disease based on a negative D-dimer in patients with a 
high pretest probability. Therefore, we additionally conducted a sensitivity analysis on the performance 
of D-dimer restricted to this subgroup of patients with a high pretest probability. Furthermore, as cancer 
is known to affect D-dimer levels, we performed a sensitivity analysis restricted to patients without 
cancer [16]. All statistical analyses were performed using Stata version 15.0 (Stata Corporation LP, 






Of the 1765 included patients with a suspected DVT, a total of 293 were diagnosed with DVT, yielding an 
overall prevalence of 16.6% (95% CI 14.9%-18.4%). Baseline characteristics are presented in Table 1. Age, 
sex and duration of symptoms were essentially similar between the two groups. The majority (81%) of 
the DVT patients had a Wells score of ≥2 points (i.e. ‘DVT likely’), while the non-DVT patients had an 
approximately equal distribution between ‘DVT unlikely’ (<2 points) and ‘DVT likely’ (52% and 48% 
respectively).  
 
Fixed D-dimer as a stand-alone test 
Of the 1765 included patients, 491 (27.8%) had a negative D-dimer and would have been sent home 
without further testing if D-dimer as a stand-alone test was the chosen diagnostic strategy (Fig. 2). Since 
this approach was not applied during the study period, 185 were referred for imaging testing despite a 
negative D-dimer. Of the patients referred for imaging testing, 134 had a Wells score of ≥2 points, while 
51 were referred despite both a negative D-dimer and Wells score <2 points. Of the 185 patients 
referred for CUS or venography despite a negative D-dimer, eight were diagnosed with DVT during their 
first visit to the Emergency Department. In addition, one patient was diagnosed with DVT during the 
three months follow-up. Of the nine DVTs in patients with a negative D-dimer, six were distal and three 
were proximal. Of the remaining 306 patients in whom DVT was ruled out due to a negative D-dimer and 
no CUS was performed, no patient was diagnosed with DVT during the follow-up period. Thus, a total of 
nine patients with a negative D-dimer were diagnosed with DVT, resulting in a failure rate of 1.8% (95% 
Cl 0.8-3.5%) for D-dimer as a stand-alone test (Table 2). D-dimer as a stand-alone test required 1274 
referrals (72.2%, 95% CI 70.0%-74.3%) for CUS. When the modified Wells score was combined with fixed 
D-dimer, the number of undiagnosed DVTs were reduced to five patients, one proximal, yielding a failure 
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rate of 1.6% (95% CI 0.5-3.6%). The combined strategy required 1443 referrals (81.8%, 95% CI 79.9%-
83.5%) for CUS (Table 2).  
In the sub-analysis restricted to proximal DVT, three of the 491 patients with a negative D-dimer 
were diagnosed with DVT (Fig. S2), yielding a failure rate of 0.6% (95% CI 0.1-1.8%) for D-dimer as a 
stand-alone test (Table 3). In the combined strategy, one patient was diagnosed with a proximal thrombi, 
and the corresponding failure rate for this strategy was 0.3% (95% 0.0-1.7%). 
 
Age-adjusted D-dimer as a stand-alone test 
Age-adjusted D-dimer as a stand-alone test would have resulted in 13 missed DVTs, corresponding to a 
failure rate of 2.0% (95% CI 1.1%-3.4%) (Table 2). Of these 13 patients, nine were diagnosed with a distal 
thrombus, yielding a failure rate of 0.6% (95% CI 0.2-1.6%) in the sub-analysis restricted to proximal DVT 
(Table 3). The modified Wells score in combination with the age-adjusted D-dimer test yielded five 
undiagnosed DVTs (failure rate 1.2%, 95% CI 0.4-2.9%). One of these undiagnosed DVTs was a proximal 
thrombosis yielding a failure rate of 0.2% (95% CI 0.0-1.4%) in the analysis restricted to proximal DVT 
(Table 3).  
 
Sensitivity analyses restricted to patients with high pretest probability and non-cancer patients  
In our study population, 169 patients with a high pretest probability had a negative D-dimer. Of these 
169 patients, four patients were diagnosed with DVT, yielding a failure rate of 2.4% (95% CI 0.6-6.0%) in 
this particular subgroup. Two of these four patients were diagnosed with proximal DVT, yielding a failure 
rate of 1.2% (95% CI 0.1-4.2%) when restricted to proximal DVTs. 
Only one cancer patient with a D-dimer level <500 ng/mL was diagnosed with DVT, and the 
analyses restricted to patients without cancer showed similar results as the main analysis for all 




In the present study, we investigated the safety and efficiency of D-dimer as a stand-alone test for ruling 
out DVT. With a fixed cut-off value of 500ng/mL, D-dimer as a stand-alone test performed similarly as D-
dimer combined with Wells score (failure rate 1.8%, versus 1.6%), but necessitated fewer CUS (72.2% 
versus 81.8%). The majority of the misclassified patients (i.e., false negative test) had a distal DVT (6/9). 
Thus, when we restricted our analysis to proximal DVT, the failure rate for D-dimer as a stand-alone test 
was 0.6% and the proportion of required CUS was reduced from 81.8% for the combined strategy to 
72.2% for the stand-alone test. Our findings suggest that D-dimer as a stand-alone test is as safe as D-
dimer combined with Wells score to rule out DVT and necessitates 12% fewer ultrasound examinations.  
Frønæs et al. previously evaluated the safety of D-dimer as a stand-alone test in patients with 
suspected DVT [21]. Among the 913 patients included in their study, 33% had a negative D-dimer (<500 
ng/mL), while the prevalence of diagnosed DVT was 18.9%. D-dimer as a stand-alone test yielded a 
failure rate of 0.3% while the proportion of required CUS was reduced from 76.9% (D-dimer combined 
with Wells score) to 67.4% (D-dimer as a stand-alone test) [21]. Our study included twice as many 
patients, and there was no selection of participants in the emergency department. A total of 28% of the 
study population had a negative D-dimer, while the prevalence of diagnosed DVT in our study was 
16.5%. The failure rate for D-dimer as a stand-alone test was higher in our study (1.8% versus 0.3%), but 
the majority of the “false negative” patients in our study had a distal DVT (67%). In contrast to the study 
by Frønæs et al., patients with uncertain CUS findings in our study were referred for contrast venography 
for further testing. By using this highly sensitive diagnostic test, we would likely detect more distal DVTs 
than by CUS alone [28]. Consequently, the different practice in objective testing, in addition to different 
study designs, could partly explain the higher failure rate in our study.  
In the present study, the failure rate was lower when we restricted our analyses to proximal DVT. 
While proximal thrombosis is considered a serious condition with a potentially severe outcome, the 
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clinical significance of distal DVT is debated [1, 25]. In some centers, CUS is only performed in proximal 
veins and normally repeated after one week in those with an initial negative test to ensure that there is 
no proximal thrombus extension. With this approach, distal DVTs are not detected and thus left 
untreated. As our study was a post hoc analysis of current clinical practice, we do not know whether the 
distal DVTs detected in our study would have progressed or not if they were left untreated. Therefore, 
our findings should be confirmed in a prospective management study using D-dimer as a stand-alone 
test. 
The failure rate, often considered as the posttest probability in VTE diagnostics, is commonly 
used to validate diagnostic strategies for VTE [1, 3, 29]. Based on the performance of venography, which 
is generally accepted as the reference standard within DVT diagnostics, a failure rate estimate of less 
than 2% is considered an acceptable degree of safety for a diagnostic pathway [30]. In our study, the 
failure rate of D-dimer as a stand-alone test for exclusion of all DVTs (including the distal DVTs) was 1.8%, 
but the upper limit of the 95% CI exceeded the recommended 2% limit. However, when restricting the 
outcome to proximal DVTs, the upper limit of 95% CI was less than 2%. D-dimer as a stand-alone test 
may therefore be safe to exclude proximal DVTs, but not distal DVTs. In a large individual patient level 
meta-analysis of more than 10 000 patients with suspected DVT, the failure rate for D-dimer in 
combination with a Wells score ≤1 point was 1.2% with a 95% CI ranging from 0.7% to 1.8% [31]. Thus, 
the failure rates observed in our study for D-dimer as a stand-alone test to exclude proximal DVT 
corresponded well with those of current practice. This further supports that D-dimer as a stand-alone 
test may be safely used to exclude proximal DVT. Finally, the strategy compares satisfactorily to the 
failure rate observed for CUS, which is estimated to range between 0.6% and 2.0% [32, 33]. 
In the subanalysis restricted to patients with a high pretest probability, the failure rate for 
proximal DVT was 1.2%. Due to limited statistical power of such a small subanalysis (n=169), the point 
estimate and the following 95% CI should be interpreted with caution. Nevertheless, the point estimate 
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for the failure rate of proximal DVT was below the suggested 2% cut-off even when restricted to those 
with a high pretest probability.  
An age-adjusted cut-off value has been suggested to increase the usefulness of D-dimer among 
elderly [34]. In our analysis, age-adjusted D-dimer as a stand-alone test would have led to a further 
reduction in required CUS of 8.9% percentage points compared to fixed D-dimer as a stand-alone test. 
However, this approach misdiagnosed additional four DVT patients, yielding a failure rate of 2.0%. While 
this failure rate is on the 2% threshold, the fixed D-dimer as a stand-alone test provided a slightly higher 
degree of safety, and due to its simplicity, one may therefore argue that the fixed D-dimer is a more 
favorable strategy.  
Large campaigns, such as the ‘Choosing Wisely’ by The American Board of Internal Medicine 
Foundation, have in recent years increased the focus on unnecessary medical tests and why they should 
be avoided [35]. One of the main advantages of using D-dimer as a stand-alone test is the reduction of 
required CUS. Although CUS is a low-risk procedure, the examination is resource demanding. As only a 
minority of patients with a suspected DVT have the disease, a reduction of CUS could increase the 
efficiency of the diagnostic work-up [7]. 
The main strength of our study is the inclusion of consecutive patients with suspected DVT within 
a confined geographical area for ten subsequent years, yielding a relatively large and unselected study 
population. Furthermore, the same diagnostic work-up, including the same high sensitive D-dimer assay, 
was used during the entire study period. Moreover, all diagnostic work-up of VTE in the region is carried 
out at the UNN, which enhances the likelihood of a complete 3-month follow-up for those living within 
the catchment area of this hospital. Our study has some limitations that need to be addressed. First, as 
our study retrospectively applied the diagnostics strategies, the results for the diagnostics strategies are 
only theoretical estimates of the diagnostic performances. Consequently, clinical aspects in the 
implementation of D-dimer as a stand-alone test are not revealed, and our findings must be further 
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validated in a prospective management study. Furthermore, the study only investigates the diagnostic 
work-up among outpatients, while D-dimer’s performance among inpatients is likely to differ [36, 37]. 
Our findings suggest that D-dimer as a stand-alone test may be safe for excluding proximal DVT 
in outpatients. This strategy has the potential to simplify and increase the efficiency of the diagnostic 
work-up for patients with suspected DVT. Since our study was conducted as a post hoc analysis, future 
prospective management studies are warranted to confirm our findings and investigate the safety of D-
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Table 1 Demographics and patients characteristics.  
 All  DVT  No DVT  
 n=1765 n=293 n=1472 
Age, years, median (IQR) 63 (28) 65 (29) 62 (27) 
Symptoms duration, days, median (IQR) 5 (12) 5 (11) 5 (12) 
Female sex, n (%) 969 (55) 141 (48) 828 (56) 
Modified Wells score DVT likely, n (%) 948 (54) 237 (81) 711 (48) 
Modified Wells score DVT unlikely, n (%) 817 (46) 56 (19) 761 (52) 
Previous DVT, n (%) 252 (15) 73 (27) 179 (13) 
Active cancer within past 6 months, n (%) 77 (4) 24 (8) 53 (4) 




Table 2 Diagnostic performance of the different strategies (n=1765) 
 Fixed D-dimer  Age-adjusted D-dimer  
  with Wells score ≥ 2  with Wells score ≥ 2 
Sensitivity     
TP/(TP + FN) 284/293 288/293 280/293 288/293 
Estimate,% 96.9 % 98.3 % 95.6 % 98.3 % 
95 % CI 94.2-98.6 96.1-99.4 92.5-97.6 96.1-99.4 
Specificity     
TN/(TN + FP) 482/1472 317/1472 635/1472 397/1472 
Estimate, % 32.7 % 21.5 % 43.1 % 27.0 % 
95 % CI 30.3-35.2 19.5-23.7 40.6-45.7 24.7-29.3 
Negative predictive value      
TN/(TN + FN) 482/491 317/322 635/648 397/402 
Estimate, % 98.2 % 98.4 % 98.0 % 98.8 % 
95 % CI 96.5-99.2 96.4-99.5 96.6-98.9 97.1-99.6 
Positive predictive value     
TP/(TP + FP) 284/1274 288/1443 280/1117 288/1363 
Estimate, % 22.3 % 20.0 % 25.1 % 21.1 % 
95 % CI 20.0-24.7 17.9-22.1 22.5-27.7 19.0-23.4 
Failure rate     
FN/(FN + TN) 9/491 5/322 13/648 5/402 
Estimate, % 1.8 % 1.6 % 2.0 % 1.2 % 
95 % CI 0.8-3.5 0.5-3.6 1.1-3.4 0.4-2.9 
Required CUS     
(TP + FP)/(TP + FN + FP + TN) 1274/1765 1443/1765 1117/1765 1363/1765 
Estimate, % 72.2 % 81.8 % 63.3 % 77.2 % 
95 % CI 70.0-74.3 79.9-83.5 61.0-65.5 75.2-79.2 
Abbreviations: CI, confidence interval; TP, true positive; TN, true negative; FP, false positive; FN, false 




Table 3 Diagnostic performance of the different strategies for exclusion of proximal DVT (n=1765) 
 Fixed D-dimer  Age-adjusted D-dimer  
  with Wells score ≥ 2  with Wells score ≥ 2 
Sensitivity     
TP/(TP + FN) 185/188 187/188 184/188 187/188 
Estimate, % 98.4 % 99.5 % 97.9 % 99.5 % 
95 % CI 95.4-99.7 97.1-100.0 94.6-99.4 97.1-100.0 
Specificity     
TN/(TN + FP) 488/1577 321/1577 644/1577 401/1577 
Estimate, % 30.9 % 20.4 % 40.8 % 25.4 % 
95 % CI 28.7-33.3 18.4-22.4 38.4-43.3 23.3-27.7 
Negative predictive value      
TN/(TN + FN) 488/491 321/322 644/648 401/402 
Estimate, % 99.4 % 99.7 % 99.4 % 99.8 % 
95 % CI 98.2-99.9 98.3-100.0 98.4-99.8 98.6-100.0 
Positive predictive value     
TP/(TP + FP) 185/1274 187/1443 184/1117 187/1363 
Estimate, % 14.5 % 13.0 % 16.5 % 13.7 % 
95 % CI 12.6-16.6 11.3-14.8 14.3-18.8 11.9-15.7 
Failure rate     
FN/(FN + TN) 3/491 1/322 4/648 1/402 
Estimate, % 0.6 % 0.3 % 0.6 % 0.2 % 
95 % CI 0.1-1.8 0.0-1.7 0.2-1.6 0.0-1.4 
Required CUS     
(TP + FP)/(TP + FN + FP + TN) 1274/1765 1443/1765 1117/1765 1363/1765 
Estimate, % 72.2 % 81.8 % 63.3 % 77.2 % 
95 % CI 70.0-74.3 79.9-83.5 61.0-65.5 75.2-79.2 
Abbreviations: CI, confidence interval; TP, true positive; TN, true negative; FP, false positive; FN, false 







Fig. S1 Strategies in the diagnostic work-up of DVT. 











Fig. S3 Fixed D-dimer as a stand-alone test for excluding deep vein thrombosis, including all patients on 





Table S1 Diagnostic performance of different strategies after exclusion of cancer patients (n=1688) 
 Fixed D-dimer  Age-adjusted D-dimer  
  with Wells score ≥ 2  with Wells score ≥ 2 
Sensitivity     
TP/(TP + FN) 261/269 264/269 257/269 264/269 
Estimate, % 97.0 % 98.1 % 95.5 % 98.1 % 
95 % CI 94.2-98.7 95.7-99.4 92.3-97.7 95.7-99.4 
Specificity     
TN/(TN + FP) 470/1419 312/1419 618/1419 390/1419 
Estimate, % 33.1 % 22.0 % 43.6 % 27.5 % 
95 % CI 30.7-35.6 19.9-24.2 41.0-46.2 25.2-29.9 
Negative predictive value      
TN/(TN + FN) 470/478 312/317 618/630 390/395 
Estimate, % 98.3 % 98.4 % 98.1 % 98.7 % 
95 % CI 96.7-99.3 96.4-99.5 96.7-99.0 97.1-99.6 
Positive predictive value     
TP/(TP + FP) 261/1210 264/1371 257/1058 264/1293 
Estimate, % 21.6 % 19.3 % 24.3 % 20.4 % 
95 % CI 19.3-24.0 17.2-21.4 21.7-27.0 18.3-22.7 
Failure rate     
FN/(FN + TN) 8/478 5/317 12/630 5/395 
Estimate, % 1.7 % 1.6 % 1.9 % 1.3 % 
95 % CI 0.7-3.3 0.5-3.6 1.0-3.3 0.4-2.9 
Required CUS     
(TP + FP)/(TP + FN + FP + TN) 1210/1688 1371/1688 1058/1688 1293/1688 
Estimate, % 71.7 % 81.2 % 62.7 % 76.6 % 
95 % CI 69.5-73.8 79.3-83.1 60.3-65.0 74.5-78.6 
Abbreviations: CI, confidence interval; TP, true positive; TN, true negative; FP, false positive; FN, false 
negative; CUS, compression ultrasound 
 
 
 
 
 
 
 
 
 
